Evidence map›Paper›PMID 22929760›Full record

ArticleThe American journal of gastroenterology2012

Alcohol and tobacco lower the age of presentation in sporadic pancreatic cancer in a dose-dependent manner: a multicenter study.

Michelle A Anderson, Eugene Zolotarevsky, Kristine L Cooper, Simon Sherman, Oleg Shats, David C Whitcomb, Henry T Lynch, Paola Ghiorzo, Wendy S Rubinstein, Kristen J Vogel and 9 more

Abstract readMulticenter Study
In one paragraph

Article in The American journal of gastroenterology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 70 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Article
  4. Idiopathic chronic pancreatitis: clinical highlights.Therapeutic advances in gastroenterology · 2026
    Review
  5. DNA Damage and Repair in Pancreatic Cancer-The Latest Findings.International journal of molecular sciences · 2025
    Review
  6. Pancreatic Cancer: A Review of Risk Factors.Life (Basel, Switzerland) · 2024
    Review
  7. Article
  8. Systemic Diseases and Gastrointestinal Cancer Risk.Journal of cancer & allied specialties · 2023
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 2 countries.

Michelle A AndersonDivision of Gastroenterology, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, USA. maaander@umich.edu
Eugene Zolotarevsky
Kristine L Cooper
Simon Sherman
Oleg Shats
David C Whitcomb
Henry T Lynch
Paola Ghiorzo
Wendy S Rubinstein
Kristen J Vogel
Aaron R Sasson
William E Grizzle
Marsha A Ketcham
Shih-Yuan Lee
Daniel Normolle
Caitlyn M Plonka
Amy N Mertens
Renee C Tripon
Randall E Brand
Michigan Medicine · USUniversity of Nebraska Medical Center · USNorthShore University HealthSystem · USUniversity of Pittsburgh Medical Center · USA. Alfred Taubman Health Care Center · USCreighton University · USUniversity of Genoa · ITUniversity of Pittsburgh · US

Funding

UAB / UMN SPORE in Pancreatic CancerP50CA101955 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BUCHSBAUM, DONALD J · 2010 to 2014
$11.1M
Biostatistics Training Program in Cancer ResearchT32CA083654 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Veerabhadran Baladandayuthapani, Kelley McLain Kidwell · 2002 to 2026
$4.3M
Enhancing the Biomedical Computing Platform for Pancreatic Cancer ResearchR01CA140940 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI SHERMAN, SIMON · 2010 to 2014
$1.5M
Validation Study of Select Biomarkers for the Diagnostic of Pancreatic CancerK23DK082097 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ANDERSON, MICHELLE ANN · 2008 to 2012
$902k
NCI NIH HHS R01 CA140940NCI NIH HHS T32 CA 083654NCI NIH HHS T32 CA083654NIDDK NIH HHS K23 DK082097
6 · The paper itself

Abstract

objectivesThe objective of this study was to examine the association between tobacco and alcohol dose and type and the age of onset of pancreatic adenocarcinoma (PancCa).

methodsProspective data from the Pancreatic Cancer Collaborative Registry were used to examine the association between age of onset and variables of interest including: gender, race, birth country, educational status, family history of PancCa, diabetes status, and tobacco and alcohol use. Statistical analysis included logistic and linear regression, Cox proportional hazard regression, and time-to-event analysis.

resultsThe median age to diagnosis for PancCa was 66.3 years (95% confidence intervals (CIs), 64.5-68.0). Males were more likely than females to be smokers (77% vs. 69%, P=0.0002) and heavy alcohol and beer consumers (19% vs. 6%, 34% vs. 19%, P<0.0001). In univariate analysis for effects on PancCa presentation age, the following were significant: gender, alcohol and tobacco use (amount, status and type), family history of PancCa, and body mass index. Both alcohol and tobacco had dose-dependent effects. In multivariate analysis, alcohol status and dose were independently associated with increased risk for earlier PancCa onset with greatest risk occurring in heavy drinkers (HR 1.62, 95% CI 1.04-2.54). Smoking status had the highest risk for earlier onset pancreatic cancer with a HR of 2.69 (95% CI, 1.97-3.68) for active smokers and independent effects for dose (P=0.019). The deleterious effects for alcohol and tobacco appear to resolve after 10 years of abstinence.

conclusionsAlcohol and tobacco use are associated with a dose-related increased risk for earlier age of onset of PancCa. Although beer drinkers develop pancreatic cancer at an earlier age than nondrinkers, alcohol type did not have a significant effect after controlling for alcohol dose.

Indexed as

AdenocarcinomaAgedAge of OnsetAlcohol DrinkingBody Mass IndexChi-Square DistributionFemaleHumansLinear ModelsMaleMiddle AgedPancreatic NeoplasmsProportional Hazards ModelsProspective StudiesRegistriesRisk Factors

Identifiers

PMID22929760
PMCPMC3923585
OpenAlexW2089544143

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.